Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Cancer. 2017 Dec 19;124(5):1025–1035. doi: 10.1002/cncr.31184

Figure 2. Single-nucleotide polymorphisms that are associated with bone mineral density (BMD) Z-score changes from diagnosis to week 120 of continuation therapy.

Figure 2

Data are adjusted for age at diagnosis, treatment risk, BMD Z-scores at diagnosis, and ancestry group. Manhattan plots (A) and box plots (B and C) for COL11A1 and NELL1 are shown.

HHS Vulnerability Disclosure